← Back to headlines
Pelthos Therapeutics Misses GAAP EPS, Beats Revenue Estimates in Q4
Pelthos Therapeutics reported a GAAP EPS of -$6.87, missing estimates, but its revenue of $9.39 million surpassed expectations for the quarter.
19 Mar, 10:36 — 19 Mar, 10:36
Sources
Showing 1 of 1 sources
